The market taxonomy of absorbable hernia mesh by type differentiates material science, degradation kinetics, and biomechanical performance, each factor influencing procurement decisions. Synthetic absorbable meshes dominate with an estimated 60 % share, primarily composed of polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL). PLA offers slower hydrolysis, extending tensile support to 12‑18 months, while PGA degrades within 6‑9 months, suiting low‑tension repairs. PCL’s long‑term stability up to 24 months addresses complex abdominal defects. Biologic absorbable meshes represent roughly 30 % of the market, derived from collagen matrices of porcine or bovine origin; their inherent tissue integration reduces foreign‑body response but incurs higher cost and variable resorption rates. Composite meshes, accounting for the remaining 10 %, blend synthetic polymers with biologic coatings to balance early strength and later remodeling. The type‑specific adoption curve mirrors clinical guidelines that prioritize rapid absorption for contaminated fields and longer‑lasting support for high‑load zones, thereby shaping the overall market size through differentiated pricing, reimbursement, and surgeon preference.